Arcellx (ACLX)
(Delayed Data from NSDQ)
$72.08 USD
+0.94 (1.32%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $72.14 +0.06 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Arcellx, Inc. has a market cap of $3.92B, which represents its share price of $71.14 multiplied by its outstanding shares number of 55.11M. As a mid-cap company, ACLX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACLX 72.08 +0.94(1.32%)
Will ACLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACLX
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates
ACLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
5 Biotech Breakthrough Stocks to Watch in 2025
Other News for ACLX
Arcellx (ACLX) Price Target Boosted by Scotiabank
Arcellx price target raised by $40 at Scotiabank, here's why
4 Analysts Assess Arcellx: What You Need To Know
Scotiabank Raises Price Target for ACLX to $133 While Maintaining Sector Outperform Rating | ...
Bullish Two Hundred Day Moving Average Cross - ACLX